South Africa’s Wits Centre Reaches Historic 1,000 Liver Transplants

JOHANNESBURG, SOUTH AFRICA — The Wits Donald Gordon Medical Centre has achieved a historic milestone by completing its 1,000th liver transplant procedure since program inception in 2004. This accomplishment highlights a major south africa liver transplant achievement, cementing the nation’s position as a continental leader in specialized hepatic surgical innovation.
The center performs between 50 and 60 liver transplants annually. Jerome Loveland, Head of Transplant Surgery, emphasized the facility’s exclusive use of machine perfusion technology in Africa. This technique circulates warm, oxygenated fluid through donor livers during preservation to assess organ viability and restore metabolic function. The innovation allows surgeons to resuscitate organs from older donors, expanding the eligible donor pool by 10 to 15 percent in a region where over 4,000 people remain on organ waitlists.
Core Program Benchmarks & Surgical Innovations
The Wits Donald Gordon program combines advanced organ preservation with specialized surgical methods:
| Programmatic Pillar | Benchmarks & Operational Metrics | Surgical Impact |
| Transplant Volume | 1,000 completed transplants (50–60 annually) | Establishes high-volume surgical expertise |
| Machine Perfusion | 10–15% donor pool expansion | Resuscitates marginal and older donor organs |
| Recipient Survival | >80% 5-year post-transplant survival rate | Advanced immunosuppression & perioperative care |
| Technological Firsts | Split-liver & living donor liver transplantation | Enables pediatric transplants & relative donations |
Expanding the South Africa Liver Transplant Capacity Across the Continent
Beyond machine perfusion, the south africa liver transplant program leverages split-liver procedures—dividing a single donor liver to benefit two recipients—which significantly improves pediatric access. Living donor options further expand organ availability by utilizing the liver’s natural regenerative capacity for safe relative-to-patient donations. Modern immunosuppressive protocols and refined surgical techniques have pushed 5-year recipient survival rates past 80 percent.
Despite these advancements, waitlist mortality remains a major challenge due to severe organ shortages. Broader healthcare equity concerns also persist, as private sector facilities serve wealthier patients while public transplant capacity remains constrained. To widen its impact, the center conducts international fellowship programs to train surgeons from across Africa, expanding complex organ preservation and hepatic transplantation capabilities across the continent.
Why It Matters: South Africa’s liver transplant leadership using machine perfusion innovation advances African surgical capacity and demonstrates the potential for medical technology adaptation.
Source: AllAfrica, September 14-15, 2026,



